Delivery Order SPE2DB20D1100-SPE2DB25FE0GW
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $8,894.37 to AmerisourceBergen Drug Corp for TALTZ 80 MG/ML Autoinjector on August 25, 2025, with completion scheduled for August 26, 2025. This competitive award, utilizing firm fixed pricing with no set-aside designation, represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The product will be delivered to the company's corporate office...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $17,287.82 by the Defense Logistics Agency (DLA) on September 2, 2025, for the supply of TALTZ 80 mg/ml autoinjector medication. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of September 3, 2025, and performance based in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a delivery order valued at $6,702.09 to AmerisourceBergen Drug Corp for TALTZ 80 mg/mL auto-injector 2-packs on July 15, 2025, with completion targeted for July 16, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a $999,999,999.00 ceiling and runs through December 2026....
- The Defense Logistics Agency awarded a $21,972.38 delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of TALTZ 80 mg/mL autoinjectors. This firm fixed-price delivery order, which is expected to be completed by August 25, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The award was made through open competition with no set-aside...
- The Defense Logistics Agency awarded a delivery order valued at $5,055.05 to AmerisourceBergen Drug Corp for TALTZ 80 mg/ml autoinjector on September 10, 2025, with completion scheduled for September 11, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (contract SPE2DX), valued at $999,999,999.00 and extending through December 2026. The product...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of TALTZ 80 mg/ml auto-injector two-packs with a ceiling value of $8,391.13. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania, with an ultimate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for TALTZ 80 MG/ML Auto-Injector with a ceiling value of $6,500.68 under firm fixed pricing. This non-competitive delivery order is scheduled for completion by August 25, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. TALTZ (ixekizumab) is a prescription biologic medication used to treat inflammatory conditions, and the auto-injector formulation provides...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 2, 2025, for the supply of TALTZ 80 mg/ml auto-injectors, with a ceiling value of $12,872.48 and an ultimate completion date of June 3, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. TALTZ (ixekizumab) is a biologic immunosuppressant medication...
- The Defense Logistics Agency awarded a $15,104.93 firm fixed-price delivery order to AmerisourceBergen Drug Corp for TALTZ 80 mg/ml autoinjector on May 16, 2025, with an ultimate completion date of May 19, 2025. This contract is a non-set-aside award and represents a child order under AmerisourceBergen's larger indefinite delivery contract vehicle with the DLA. The place of performance is the contractor's corporate office in Conshohocken, Pennsylvania. TALTZ (ixekizumab) is a biologic...
- The Defense Logistics Agency awarded a $22,497.98 delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for TALTZ 80 mg/ml autoinjector supply. This is a firm fixed price, non-set-aside contract with a completion date of August 15, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FE0GWDelivery Order
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $8,399.82 for TALTZ 80 MG/ML AutoInjector on September 17, 2025, with completion scheduled for September 18, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999.99 million through December 2026. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters as a major pharmaceutical distributor serving federal medical procurement needs. TALTZ (ixekizumab) is a biologic medication used to treat inflammatory conditions, and this autoinjector formulation represents part of AmerisourceBergen's comprehensive pharmaceutical supply portfolio supporting military and veteran healthcare systems. The broader SPE2DX IDC enables the company to supply a wide range of pharmaceutical products, specialty medications, vaccines, and medical supplies globally to support Defense Health Agency operations and other federal healthcare systems. As a non-set-aside award, this delivery order was competitively procured and reflects AmerisourceBergen's established capability to fulfill federal medical supply requirements through its primary vendor relationship with DLA.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.4k | 9/17/25 |